Results from the OCEANIC-STROKE trial show that the investigational Factor XIa inhibitor, asundexian, not only reduces the ...

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

Upadacitinib is effective in inducing clinical response and remission and is generally well tolerated in patients with ...

A US study found that giving oseltamivir to ≥ 70% of nursing home residents within 48 hours of an outbreak cut ...

The Alberta government has proposed a voucher program for patients who have waited longer than is recommended for surgery.

The American Board of Pediatrics’ new subspecialty training model aims to improve readiness for practice as well as ...

Plant-based protein consumption is associated with a lower risk for CVD, but its effects depend on food quality, processing, ...

The use of calcitonin gene-related peptide (CGRP) inhibitors to treat adults with migraine is linked to a 25% lower risk for ...

Researchers highlight that age, not ovarian reserve, drives fertility decline, thereby questioning the clinical value of ...

A new study integrates multiple genetic risk scores to better identify people at high risk for eight cardiovascular ...

A blood test measuring levels of basophil activation markers identifies sesame seed allergy more accurately than skin prick ...

Dual-energy CT with virtual non-calcium reconstruction provides high specificity in detecting bone marrow oedema in ...